DNA helix

From a female scientist to a scientist who was female – explored by Hannah Kossowska-Peck. Today we should not celebrate her for being a female scientist, nor a ‘feminist’ scientist, but an accomplished scientist. International Women’s Day is a time to focus on the wonderful women in society, both currently and historically. One such woman is Rosalind Franklin, who graduated from Newnham College, Cambridge in 1941 and went on to

FOCUS: The Earth as a Natural Living Laboratory

BlueSci presents three perspectives on how scientists have expanded our understanding of science using the greatest laboratory of all – planet Earth. We begin with a piece by Bryony Yates, on using Earth’s biosphere in the study of life. HUMANS HAVE LONG been fascinated with the natural world, as pre-historic paintings of plants and animals so beautifully illustrate. We can trace formal scientific study back to Ancient Greek philosophers, with

Let's Talk About Soil

Kasparas Vasiliauskas looks under our feet at some of the Earth’s most overlooked material. Met in almost every step we take, soils, despite being so familiar, are often overlooked in discussions of natural systems. This is evident, for example, in making climate models and predictions and even more so when thinking about humanity’s future outside Earth. The entirety of soils and the space where their formation takes place is called

Walking in the footsteps of robotic fossils

Robot of ancient fossil enables scientists to model gait Ripples are forming at the surface of a glass of water; scared children huddle at the back of a car; ominous footsteps resonate on the not-so-distant-anymore horizon. And suddenly, it appears: swinging its tail side-to-side, little arms tucked on the side, a T-rex makes its way into the frame, walking its characteristic walk. But how do we know which gait the now (thankfully) extinct giant adopted? Fossils can

Scientists work together to create more effective medicines Advances continue to progress personalised medicine, a field in which drugs are tailored to patients’ needs based on their genetic information. Historically, simply screening patients’ genomes enabled this trend but more recently, synthetic nucleotide-based medicines have taken this a step further. Nucleotide-based medicines use artificial DNA and RNA (nucleotides) to target cellular genetic information directly, shutting off genetic diseases at their source.